2020 ASCO Virtual Direct™ Highlights
2020 Update on Esophagogastric Cancers: Did T-DXd Demonstrate Meaningful Clinical Improvements in ORR and OS vs. SoC Chemo in HER2+ Advanced Gastric/GEJ Cancer? Does the Addition of Ramucirumab to Perioperative FLOT Improve R0-resection Rates?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Daniel Lin
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Daniel Lin
Login to view comments.
Click here to Login
